C07D213/26

ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME

Disclosed is an organic compound contributing to improving the substantial light efficiency and field of view of an organic electroluminescent device. The organic electroluminescent device contains a first electrode; a second electrode; one or more organic material layers disposed between the first electrode and the second electrode; and a capping layer, wherein the organic material layers or capping layer contains an organic compound of chemical formula 1:

##STR00001##

COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF

Provided are a fluorinated compound for patterning a metal or an electrode (cathode), an organic electronic element using the same, and an electronic device thereof, wherein a fine pattern of the electrode is formed by using the fluorinated compound as a material for patterning a metal or an electrode (cathode), without using a shadow mask, and it is possible to more easily apply UDC since it is easy to manufacture a transparent display having high light transmittance.

COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF

Provided are a fluorinated compound for patterning a metal or an electrode (cathode), an organic electronic element using the same, and an electronic device thereof, wherein a fine pattern of the electrode is formed by using the fluorinated compound as a material for patterning a metal or an electrode (cathode), without using a shadow mask, and it is possible to more easily apply UDC since it is easy to manufacture a transparent display having high light transmittance.

Method for preparation of fluoro alkylated compounds by homogeneous Ni catalysis

The invention discloses a method for the preparation of fluoro alkylated compounds by homogeneous Ni catalyzed fluoro alkylation with fluoro alkyl halides in the presence of a base.

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

Compounds that inhibit HIF-2α, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by HIF-2α.

Organic electroluminescence device

The present invention relates to an electroluminescence device having high luminous efficiency (for example, external quantum efficiency) and high durability and causing little chromaticity shift after device deterioration. The present invention also relates to an organic electroluminescence device material comprising a substrate having thereon a pair of electrode and at least one organic layer between the electrodes, the organic layer containing a light emitting layer, wherein the light emitting layer contains a metal complex having a group represented by formula (I). ##STR00001##

Organic electroluminescence device

The present invention relates to an electroluminescence device having high luminous efficiency (for example, external quantum efficiency) and high durability and causing little chromaticity shift after device deterioration. The present invention also relates to an organic electroluminescence device material comprising a substrate having thereon a pair of electrode and at least one organic layer between the electrodes, the organic layer containing a light emitting layer, wherein the light emitting layer contains a metal complex having a group represented by formula (I). ##STR00001##

ERG ONCOGENE INHIBITORS
20230382862 · 2023-11-30 ·

The present disclosure relates generally to compounds suitable as ERG inhibitors, including compositions comprising such compounds, methods for their use in treating diseases associated with overexpression of wild type ERG protein, an altered ERG protein, ERG gene transcription or ERG mRNA translation, and methods of making such compounds.

ERG ONCOGENE INHIBITORS
20230382862 · 2023-11-30 ·

The present disclosure relates generally to compounds suitable as ERG inhibitors, including compositions comprising such compounds, methods for their use in treating diseases associated with overexpression of wild type ERG protein, an altered ERG protein, ERG gene transcription or ERG mRNA translation, and methods of making such compounds.

Cross-linkable organometallic light emitting ligands and complexes
11420989 · 2022-08-23 · ·

A 1, 4 bidentate ligand comprising first and second ligand centres, wherein the first ligand centre is an sp.sup.2-hybridised carbon or a nitrogen atom; wherein the second ligand centre is a nitrogen atom in a five- or six-membered aromatic or hetero-aromatic ring, said ring having a substantially linear substituent T.sup.1 meta or para to the nitrogen atom; wherein T.sup.1 has the formula 1:
—Ar.sup.1.sub.a—Y.sup.1.sub.b—Ar.sup.2—[Y.sup.2.sub.c—Ar.sup.2].sub.d—S—B  (1) and wherein T.sup.1 is attached to the ring by X.sup.1, wherein X.sup.1 is a bond, a methylene group, a substituted methylene group, an oxygen atom or a sulphur atom, wherein each Ar.sup.1 and Ar.sup.2 are independently selected from the group of C.sub.6 to C.sub.20 aromatic and C.sub.4 to C.sub.20 heteroaromatic groups, wherein Y.sup.1 and each Y.sup.2 is independently an optionally substituted C.sub.2 or acetonitrile trans double-bond linking moiety, wherein a is 0, 1, 2 or 3, wherein b is 0, 1 or 2, wherein each c is independently 0, 1 or 2, wherein d is 0, 1, 2, 3 or 4, S is a flexible spacer, and B represents a moiety having one or more cross-linkable functionalities. Network polymers, complexes, compositions, and devices based on this ligand. Method for forming devices based on this ligand.